Details for Patent: 11,186,547
✉ Email this page to a colleague
Which drugs does patent 11,186,547 protect, and when does it expire?
Patent 11,186,547 protects LENVIMA and is included in one NDA.
Protection for LENVIMA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has forty-two patent family members in twenty-six countries.
Summary for Patent: 11,186,547
| Title: | High-purity quinoline derivative and method for manufacturing same |
| Abstract: | Provided is a compound represented by formula (IV) or a salt thereof, wherein the content of the compound represented by formula (I) is 350 ppm by mass or less. |
| Inventor(s): | Taiju Nakamura, Taichi Abe, Yusuke Miyashita, Hirofumi Kuroda, Yusuke Ayata, Atsushi Akao |
| Assignee: | Eisai R&D Management Co Ltd |
| Application Number: | US17/022,675 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 11,186,547 |
|
Patent Claim Types: see list of patent claims | Compound; |
Drugs Protected by US Patent 11,186,547
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eisai Inc | LENVIMA | lenvatinib mesylate | CAPSULE;ORAL | 206947-001 | Feb 13, 2015 | RX | Yes | No | 11,186,547*PED | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| Eisai Inc | LENVIMA | lenvatinib mesylate | CAPSULE;ORAL | 206947-002 | Feb 13, 2015 | RX | Yes | Yes | 11,186,547*PED | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 11,186,547
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Japan | 2014-174062 | Aug 28, 2014 |
| Japan | 2015-034729 | Feb 25, 2015 |
International Family Members for US Patent 11,186,547
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 101695 | ⤷ Start Trial | |||
| Australia | 2015309862 | ⤷ Start Trial | |||
| Brazil | 112017002827 | ⤷ Start Trial | |||
| Canada | 2957005 | ⤷ Start Trial | |||
| China | 106660964 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
